Conjunctival and Retinal Vascularization and Small Vessel Disease
EVACORMA
Study of Conjunctival and Retinal Blood Vessels for the Evaluation of the Load of Small Vessel Disease in Patients With Transient Ischemic Attacks (TIAs) and Minor Strokes
1 other identifier
interventional
850
1 country
1
Brief Summary
The purpose of the study is to use a simple photography of conjunctival vessels to search for an association between conjunctival vessels abnormalities and the load of small vessel disease as quantified by MRI in patients with TIA s and minor strokes. The artificial intelligence (AI) tools will permit to classify abnormalities of conjunctival vessels that predict the load of small vessel disease in TIAs and strokes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2020
CompletedFirst Posted
Study publicly available on registry
June 25, 2020
CompletedStudy Start
First participant enrolled
October 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2022
CompletedAugust 31, 2021
August 1, 2021
2 years
May 8, 2020
August 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numbers of conjunctival vascular abnormalities
Association between numbers of conjunctival vascular abnormalities and the load of small cerebral disease highlighted by neural network in " deep learning ". This outcome is collected after the end of the inclusion of all patients.
day 1
Secondary Outcomes (3)
Classification of different types of vascular abnormalities in different grades of small vessel disease
Day 1
Absence of difference between the 2 eyes
Day 1
same stade of vascular abnormalities
Day 1
Study Arms (1)
Photographs
EXPERIMENTALPhotographs
Interventions
patient will have photo of their bulbar conjunctival of each eye and photography of fundus without dilatation
Eligibility Criteria
You may qualify if:
- Patients treated for a minor stroke or transient ischemic attack justifying an MRI.
You may not qualify if:
- Severe eye dryness with conjunctiva hyperhemia,
- Taking eye treatments for glaucoma
- Inflammatory or infectious eye damage resulting in conjunctiva hyperhemia: conjunctivitis, herpetic keratitis, ulcer, abscess, uveitis, peripheral ulcerative keratitis, interstitial keratitis, scleritis, episcleritis, pingueculitis, scarring eye pemphigoide, acute seizure by closing of the angle,
- History of eye surgery. Among eye surgeries, those that can modify the conjunctiva are strabismus surgeries, glaucoma, conjunctiva resection surgery (pterygial or tumor) or wound surgery or finally recent cataract surgery (2 years).
- Persons under the legal protection of adults (safeguarding justice, guardianship, curatorship, institutionalized, or under mandate of future protection)
- Administrative problems: inability to give about informed information, no coverage by a social security plan, refusal to sign a consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NASR Nathalie
Toulouse, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathalie NASR, MD
University Hospital, Toulouse
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2020
First Posted
June 25, 2020
Study Start
October 20, 2020
Primary Completion
October 20, 2022
Study Completion
October 20, 2022
Last Updated
August 31, 2021
Record last verified: 2021-08